IMRT 2018

NRG Oncology/Alliance 1306 Current Design

R A N D O M I

Stand Concurrent ChemoRT

EGFR m

Erlotinib x 12 wks

Stand Concurrent ChemoRT

Z E

Eligibility:

R E G I S T E R

Stratify:

-Stage III

-Wt. Loss

-Good PS

-IIIA vs. IIIB

EGFR m or ALK m at CLIA Lab

-Chemo (EP vs. CboTax)

R A N D O M I

Stand Concurrent ChemoRT

ALK m

Crizotinib x 12 wks

Stand Concurrent ChemoRT

Z E